The Longevity Genes in Founder Populations Project
Albert Einstein College of Medicine · with National Institute on Aging (NIA), American Federation for Aging Research · NCT00707694
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 65+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 2000
- US sites recruiting
- 2
- Study start
- July 1998
- Record last updated
- January 2, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
We believe extreme longevity is due to specific genes which function to delay aging and prevent disease. The purpose of the research is to identify the genes/mutations associated with healthier aging; to understand the biological functions of these genes/mutations; and to develop therapies to replicate these preservative genetic activities in individuals who do not have the genetic profile for longevity.
Conditions: Extreme Longevity
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Ashkenazi Jewish, age 95+,
- Offspring of person age 95+,
- Offspring of parents who died age 70 or younger.
Exclusion Criteria
- Non-Ashkenazis
Recruiting US locations
Private Homes
Site contact: Wanda I Guzman, BA · 718-430-3838 · WANDA.GUZMAN@EINSTEINMED.EDU
Hebrew Home Riverdale
Riverdale, NY 10471
Site contact: Charlotte Dell, LMSW · 718-581-1139
Study contacts (from the official record)
- Tina Gao · 718-839-7176 · tina.gao@einsteinmed.edu
Similar studies in New York
All healthy volunteers studies in New York →- RecruitingHealthy volunteers
Using Middle School Science Teachers to Address Cancer Health Disparities
Weill Medical College of Cornell University
- Location
- New York, NY + 1 other US site
- Eligibility basics
- Ages 10+
- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- New York, NY + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Staten Island, NY + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)
Merck Sharp & Dohme LLC
- Location
- East Syracuse, NY + 14 other US sites
- Eligibility basics
- Ages 2 mo–1